To access the faculty presentations, click on the links to your left, or those below.
A fascinating look at age and gender related changes in bone macro- and microarchitecture, the pathogenesis of skeletal fragility and implications for developing new agents for treating osteoporosis.
Beyond routine assessment for factors contributing to osteoporosis, this presentation will focus on difficulties encountered by clinicians in evaluating patients with osteoporosis and examine potential solutions.
Potential applications for osteo-anabolic therapy with PTH alone or in combination with other agents include enhancement of fracture healing, treatment of non-union fractures and some dental conditions.
This presentation will provide an evidence-based and clinical perspective on bisphosphonate therapy issues that include subtrochanteric fractures, drug holidays and oversuppression of bone turnover.
Current medications for the treatment of osteoporosis, how they are used, and how they could be used, all with a futuristic view of new options in familiar drug classes and drugs in development with novel mechanisms of action will be discussed.
New and controversial topics on osteoporosis and metabolic bone disease will be examined. This is an opportunity to discuss issues not addressed or insufficiently addressed in previous sessions.
Advanced instruction for DXA technologists and others interested in optimizing the quality and clinical utility of DXA studies.
A look at the role of the technologist in participating in the evaluation of osteoporosis and fracture risk assessment.
An open discussion of DXA studies that present challenges in the assessment of bone density.
